Eli Lilly, the manufacturer of Mounjaro (tirzepatide), offers a savings card program for eligible participants. Other resources may also be available to help you save on the cost of your Mounjaro ...

Shares of pharmaceutical company Organon (NYSE:OGN) fell 4.7% in the afternoon session after Barclays initiated coverage on the company with an 'Underweight' rating and a price target of $7.50. The ...

Organizations are scaling efforts nationwide to support food-insecure Americans. Across the country, food banks and community-based organizations have scaled up efforts with a call to action to help ...

Organon (OGN) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

Organon (NYSE:OGN) reported better-than-expected earnings for the third quarter on Monday. The company posted third-quarter adjusted earnings of $1.01 per share on Monday, beating the consensus ...

Organon (NYSE:OGN) reported third-quarter adjusted earnings of $1.01 per share on Monday, beating the consensus estimate of 94 cents. The global healthcare company reported quarterly sales of $1.602 ...

JERSEY CITY, N.J. (AP) — JERSEY CITY, N.J. (AP) — Organon & Co. (OGN) on Monday reported third-quarter earnings of $160 million. The Jersey City, New Jersey-based company said it had profit of 61 ...

Women’s health company Organon is selling off its postpartum uterine bleeding or hemorrhage system to Laborie Medical Technologies in a deal worth up to $465 million. Organon first gained access to ...

Oct 27 (Reuters) - Organon (OGN.N), opens new tab said on Monday CEO Kevin Ali will resign from his role, after an internal investigation into sales of its Nexplanon contraceptive implant to ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...